Picture of Nanopharmaceutics logo

TGRP Nanopharmaceutics Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Nanopharmaceutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2016
December 31st
2017
December 31st
Period Length:
Source:10-K10-K
Standards:
USG
USG
Status:FinalFinal
Cash and Equivalents
Cash and Short Term Investments0.3520.1
Net Total Accounts Receivable
Net Total Receivables0.1870.091
Total Inventory
Prepaid Expenses
Total Current Assets1.060.408
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment0.3280.258
Total Assets1.390.666
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities8.329.62
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Liabilities8.138.74
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity-6.74-8.08
Total Liabilities & Shareholders' Equity1.390.666
Total Common Shares Outstanding